Xie M, He C, Wei S, Zhang L. Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo. Eur J Cancer. 2013;49:3559-72 pubmed publisher

Ou J, Lin H, Su K, Yu S, Tseng I, Chen C, et al. Potential Therapeutic Role of Z-Isochaihulactone in Lung Cancer through Induction of Apoptosis via Notch Signaling. Evid Based Complement Alternat Med. 2012;2012:809204 pubmed publisher

Zhen Jun S, Yuan Yuan Z, Ying Ying F, Shao Ju J, Jiao Y, Xiao Wei Z, et al. ?,?-Dimethylacrylshikonin exerts antitumor activity via Notch-1 signaling pathway in vitro and in vivo. Biochem Pharmacol. 2012;84:507-12 pubmed publisher

Pinchot S, Jaskula Sztul R, Ning L, Peters N, Cook M, Kunnimalaiyaan M, et al. Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method. Cancer. 2011;117:1386-98 pubmed publisher

Rose S, Kunnimalaiyaan M, Drenzek J, Seiler N. Notch 1 signaling is active in ovarian cancer. Gynecol Oncol. 2010;117:130-3 pubmed publisher

Ning L, Wentworth L, Chen H, Weber S. Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma. Am J Transl Res. 2009;1:358-66 pubmed

Ning L, Greenblatt D, Kunnimalaiyaan M, Chen H. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells. Oncologist. 2008;13:98-104 pubmed publisher

Greenblatt D, Vaccaro A, Jaskula Sztul R, Ning L, Haymart M, Kunnimalaiyaan M, et al. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist. 2007;12:942-51 pubmed